(2R,3S)-2-[(1R)-l-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-morpholine,4-methylbenzene-sulfonate
![(2R,3S)-2-[(1R)-l-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-morpholine,4-methylbenzene-sulfonate](/46/product/103/23/42/200000-59-5.png)
Product Description
Viwit Pharmaceutical Co. Ltd
-
CN -
2015On CPHI since
-
500 - 999Employees
Company types
Categories
Specifications
Viwit Pharmaceutical Co. Ltd
-
CN
-
2015On CPHI since
-
500 - 999Employees
Company types
More Products from Viwit Pharmaceutical Co. Ltd (47)
-
Product Vildagliptin
Assay:99% -
Product (2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol
A key intermediate of Efinaconazole -
Product (2R,3S)-2-(2,4-Difluorophenyl)-3-methyl-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
A key intermediate of Efinaconazole -
Product (R)-1-(3,5-Bis-trifluoromethylphenyl)ethanol
An intermediate of Aprepitant -
Product (R)-Methyl Oxazaborolidine intermediates
Assay: 30% in toluene. -
Product (S)-2-chloro-1-(2,4-dichlorophenyl)ethyl methanesulfonate
A key intermediate of Luliconazole -
Product (S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemethanol
A key intermediate of Luliconazole
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance